U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 0) by Anonymous Coward on Wednesday January 23 2019, @09:34PM
Well you won't know that, since they are only publishing the "chargemaster" values, which are typically 2-10x higher than the real price.
Also, emergency room expenses are really far down there in terms of where healthcare spending goes. The vast majority is for chronic conditions in the elderly.